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A fixed positive charge can be placed at the N-terminus of a peptide by addition of a 
tris[(2,4,6-trimethoxyphenyl)phosphonium]acetyl group. The usefulness of these charged 
derivatives has been demonstrated in fast atom bombardment mass spectrometry and in 
matrix-assisted laser desorption/ionization mass spectrometry. After ion formation and 
acceleration, these derivatized peptide ions dissociate and their fragment ions can be 
analyzed in a postsource decay experiment by using a time-of-flight mass spectrometer. The 
matrix-assisted laser desorption/ionization-postsource decay spectra are very different from 
what may be expected based on fragment ions observed from protonated peptide molecules. 
Cleavage of CHR-C(O) bonds dominates to form a series of a-type ions. Mechanis- 
tic possibilities are evaluated. When aspartic acid residues are encountered, the chem- 
istry radically changes. This appears to be due to the formation of geometrically accessible 
intermediates that can dissociate via low energy processes. This charge-remote chemis- 
try parallels that for much simpler systems, resulting in spectra that are very easy to 
interpret. (J Am Sot Mass Spectrom 1997, 8, 501-509) 0 1997 American Society for Mass 
Spectrometry 
hen desorption/ionization techniques in 
mass spectrometry, notably fast-atom bom- 
bardment (FAB), are used in the analysis of 
peptides, gas phase protonated molecules MH+ are 
usually formed. These ions can be selected for analysis 
by tandem mass spectrometry by using collision-in- 
duced dissociation (CID) and collisionally activated 
dissociation (CAD), yielding a variety of fragment ions 
[l, 21. Peptide chains are composed of three types of 
backbone bonds that can be broken, yielding N- and 
C-terminal fragments, either of which could carry the 
charge. Thus, six possible fragment ions may be formed 
per amino acid residue. The number increases further 
because fragmentation of side chains may accompany 
backbone bond cleavage [l-3]. The chemistry is rich, 
presumably because a number of isomeric forms of 
MH* exist; peptides contain a number of basic sites on 
which the proton resides. This assumes that fragmen- 
tation occurs preferentially at, or local to, the charge 
(site of protonation) [ 11. 
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Different fragmentation pathways can be accessed if 
the charge is fixed at a single location. For example, 
the N-terminus of an analyte peptide can be modified 
by addition of a trimethylammonium acetyl (TMAA) 
group, shown in Structure 1 [4-61, to affix a permanent 
charge to this end of the molecule (R, = amino acid 
residue i). When this charge-derivatized peptide C+ is 
dcsorbed into the gas phase in a FAB experiment, 
fragmentation of many skeletal bonds may be induced, 
presumably through charge-remote processes that are 
not directly influenced by the charge, but occur when 
excess energy is deposited into the ion [ 7,8]. A number 
of charged derivatives for peptides have been devel- 
oped, and recently their performance in FAB has been 
reviewed and compared [9]. In general, charged 
derivatives of peptides generate more intense C+ sig- 
nals in FAB than those representing MH+ in the FAB 
analyses of underivatized peptides, lowering detection 
limits. Also, fewer possible fragment ions are gener- 
ated, because ions such as Structure 1 only yield N- 
terminal fragment ions. The CAD spectra of various 
charged derivatives of peptides differ in a number of 
ways. One notable difference is the extent to which the 
charged derivative fragments via skeletal peptide bond 
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(CH&h’+-CH&O-II&-----F&-OH 
Structure 1 
unique, with the cleavage of CHR-C(0) backbone 
bonds in derivatized peptides being preferred. Mecha- 
nistic aspects will be discussed in light of the influence 
of amino acid residue side chains on the facility of 
bond cleavage within individual residues. Also, ad- 
cleavage, as opposed to formation of ions representing 
only the charged group. The TMAA derivatives yield 
intense sequence-specific ions, and only a minor por- 
tion of the C+ ions fragment to yield small ions from 
the TMAA group. In contrast, when the N-methyl-4- 
pyridinium acetyl group is attached to a peptide, peaks 
representing ions from the derivatizing group domi- 
nate the CAD spectrum 191. 
vantages in the analysis of peptides by matrix-assisted 
laser desorption-ionization-postsource decay-mass 
spectrometry (MALDI-PSD-MS) by using TMPP+-AC 
derivatives are presented, and an approach to the 
interpretation of such mass spectra is discussed. 
We recently reported that charged derivatives, 
specifically the triphenyl phosphonium ethyl (TPPE) 
derivative of peptides, Structure 2, respond well in 
matrix-assisted laser desorption/ionization (MALDI) 
mass spectrometry 1101. Although not expected, 
TPPE-derivatized peptides give intense peaks in 
MALDI in some cases where the underivatized pep- 
tide gives no response at all. In linear time-of-flight 
(TOF) mass spectrometry, MALDI yields only a peak 
representing the C+ cation for such charged deriva- 
tives; however, the ions do fragment following their 
generation and acceleration. Mass spectra representing 
these fragment ions can be acquired in reflectron TOF 
experiments, and are referred to as postsource decay 
(PSD) mass spectra 111,121. Preliminary reports of PSD 
spectra of charged derivatives of peptides are avail- 
able, [13-161 and it appears that their mass spectra, 
specifically the types and distribution of fragment ions 
formed via backbone bond cleavages, vary with the 
charged group used. 
Although charged derivatives offer attractive ad- 
vantages in the mass spectrometry analysis of proteins, 
additional work is clearly required in this field. No- 
tably, the yield of the derivatizing methods varies 
considerably, and low yields seem to be common [9]. 
Recently, a new derivative, which addresses the chem- 
ical complications of previous techniques, was devel- 
oped based on the [tris(2,4,6-trimethoxyphenyl)phos- 
phoniumlacetyl (TMPP-AC) group 117, 181. Of partic- 
ular note, the presence of three methoxy groups on 
each of the three phenyl groups yields a charged 
moiety that is much more hydrophilic than that en- 
countered in the TPPE or TMAA groups. This is im- 
portant not only in the final product, but in the selec- 
tion of common solvents in the handling and prepara- 
tion of the reagents used to make these derivatives. 
Synthetic aspects of this project are discussed in ref. 
18. Reported here are the unimolecular fragmentation 
reactions which TMPP+-Ac-derivatized peptides fol- 
low in the MALDI-PSD experiment. The processes are 
Stnlcture 2 
Experimental 
All peptides were obtained from Sigma Chemical Co. 
(St. Louis, MO) and were used as purchased without 
further purification. The tris[(2,4,6-trimethoxyphenyl) 
phosphoniuml acetyl (TMPP +-AC) derivative was 
made with the charged group attached to the N- 
terminus. The synthetic aspects, reported elsewhere 
[17, 181 will be described briefly here. The reagent 
used is [TMPP+-Ac-SC,FJ[Br-I. It is made by first 
reacting bromoacetyl bromide with pentafluorothio 
phenol, and then adding tris-(2,4,6-trimeth- 
oxyphenyllphosphine to generate the salt. By using a 
1:l (v/v) water-acetonitrile solvent system, reaction 
with a peptide occurs after approximately 15-30 mm 
at room temperature. The reaction is catalyzed by 
p-dimethylaminopyridine (DMAP). All derivatization 
reactions were performed by using l-10 nmol of pep- 
tides, with a molar ratio of reactants - 1:5:10 (peptide: 
[TMPP+-Ac-SC,FJ[Br-1: DMAP). 
MALDI-PSD mass spectra were obtained on a Voy- 
ager Elite reflectron time-of-flight mass spectrometer 
(PerSeptive Biosystems, Inc., Framingham, MA) 
equipped with a nitrogen laser (337 nm, 3-ns pulse). 
The acceleration voltage used was 25 kV. Some 
MALDI-PSD spectra were obtained on a PerSeptive 
Biosystems Voyager XL equipped with delayed extrac- 
tion (DE) [19]. The delay time setting was 45 ns and 
the acceleration voltage was 20 kV. Data were acquired 
with the data system provided and based on a tran- 
sient recorder with 2-ns resolution. The matrix used 
was a-cyano-4-hydroxycinnamic acid, dissolved in 
water-acetonitrile (l:l, v/v) to give a saturated solu- 
tion at room temperature. To prepare the sample, 1 PL 
of the solution containing the peptide derivative (at 
concentrations of l-10 pmol/pL) and excess reagents 
was added to 1 PL of the matrix solution and applied 
to a stainless steel sample plate. The resulting mixture 
from the derivatization reaction was used directly. No 
purification step was attempted. The mixture was then 
allowed to air dry before being introduced into the 
mass spectrometer. Each spectrum was produced by 
accumulating data from loo-256 laser shots. The in- 
struments generate PSD data by obtaining several 
spectra, each optimized for a different range of mass- 
to-charge ratio values for the fragment ions. Selected 
regions of each are stitched together [20] to yield the 
single PSD mass spectra that are shown here. Time-to- 
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mass conversion was achieved by calibration by using 
the peak representing the C+ cation of the charged 
derivative to be analyzed. Depending on the resolution 
of the experiment, mass-to-charge ratio values used 
for calibration were either average or monoisotopic 
values. 
41 T  
i 
(a) Hi+ 
Fast-atom bombardment-collisionally activated dis- 
sociation-tandem mass spectrometry (FAB-CAD- 
MS/MS) spectra were obtained on a double-focusing 
mass spectrometer (JEOL HX-110, JEOL, Tokyo, Japan) 
by using linked B/E scans with a beam of 6-keV xenon 
atoms and a lo-kV acceleration voltage in the source. 
The FAB matrix used was thioglycerol-2-hydroxyethyl 
disulfide (l:l, v/v) [18]. Helium was used as the 
collision gas, and the abundance of the precursor ions 
was attenuated to 50% for CAD experiments. Ions 
generated by FAB from Ultramark 1621 (PCR Inc., 
Gainesville, FL) were used for instrument calibration. 
The data were acquired with a JEOL MS-MP8020D 
data system. 
[H-VGVAPG--OHJH+ 
J 
: (b) 
Results and Discussion 
Figure la and b shows the FAB high energy CAD mass 
spectra for the MH+ ion of the hexapeptide H- 
VGVAPG-OH and its TMPP+-AC derivative cation C+, 
respectively. In Figure la, the major product ions are 
labeled as b, and y,, ions according to the common 
nomenclature for fragmentation of protonated pep- 
tides. The subscript indicates the number of side chains 
in the fragment ion. The b, and yn ions both arise from 
the cleavage of skeletal C(O)-NH bonds. Mechanisms 
and fragment ion structures can be drawn with the 
amide nitrogens being the initial site of protonation [ 11. 
Consider for example, the b, designation for the ion at 
m/z 327 in Figure la. If the A-P amide bond is 
cleaved, the N-terminal fragment would have a mass 
of 327 u. One could consider the definition of a b, ion 
as one formed from the protonated peptide following 
Scheme I, in which the N of the proline residue is the 
site of protonation. 
0 200 400 600 800 1000 
m/z 
Figure 1. FAB-high energy CAD mass spectra for (a) the MH+ 
ion of the hexapeptide H-VGVAPG-OH and (b) its TMPP+-AC 
derivative cation C+. Labels are used to most accurately repre- 
sent mass. Single letter designations formally represent amino 
acid residues, and additional atoms at the termini such as H and 
OH are italicized. The mass-to-charge ratio values given are 
monoisotopic masses. For (a), 1 nmol of the peptide was used to 
obtain the spectrum. In (b), the structure of the cationic deriva- 
tized peptide is shown at the top of the figure; the mass spectral 
peak is labeled as Cf. One nanomole of the peptide was deriva- 
tized, and of this, 50 pmol were used to obtain the spectrum. 
In Scheme I, the “extra hydrogen atom,” the proton 
that gives the peptide its charge, is lost in the neutral 
fragment to yield the ion with Structure 3; the C(O)-N 
bond is cleaved heterolytically. Another option is that 
the b, ion does contain the “protonating” hydrogen. In 
this case, a H from the N-terminal fragment must be 
lost for the mass-to-charge ratio value to be correct; 
thus, Structure 4 may more accurately represent b, 
ions from some protonated peptides, where the proton 
could reside at any of a number of basic sites in the 
molecule. Recently, other possible structures for b, 
ions have been evaluated, including electrostatically 
bound ion-molecule complexes [21] and cyclic geome- 
tries [22]. 
d-type ions are formed. There is a complete a-type ion 
sequence observed, with only the a2 ions in low abun- 
dance. When valine residues are involved, fairly abun- 
dant d-type ions due to side chain losses are observed, 
labeled as d, and d, in Figure lb. The peaks appearing 
in the region of the spectrum below m/z 600 corre- 
spond to TMPP+-AC moiety-related ions. There are no 
intense signals observed in this region-an advantage 
of this charged derivative. 
0 no 
H-VGV-NH-CH(CH,)-;r+N-CH-&G-OH 
A 
The spectrum in Figure lb is very different. All of 
the fragment ions represent N-terminal fragments, as 
expected for an N-terminal charged derivative. How- 
ever, there are no b-type ions formed; instead, a- and 
51 m 
H-VGV-NH-CH(CH,)-C+ + HN-CH-C-G-OH 
Structure 3 
Scheme I 
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[H-VGV-NH-C(CH,)=C=O]H+ 
Structure 4 
Ions representing the peaks in Figure lb are referred 
to as “a-type” and “d-type” ions, because the a/d 
nomenclature refers to ions from protonated peptides 
1231. The nomenclature can be used for ions from 
charged derivatives, but its use must be clearly de- 
fined. For the TMPP+-AC-VGVAPG-OH spectrum in 
Figure lb, peaks are labeled with a-type designations 
because they arise from cleavage of skeletal CHR-C(O) 
bonds, as in the scheme used for protonated peptides. 
Consider the peak at m/z 644, labeled as a,. Scheme II 
shows that if the CHR-C(O) bond in the N-terminal 
valine is broken homolytically, it would result in an 
N-terminal fragment ion with m/z 645. The observed 
mass, 1 u lower, indicates that this N-terminal frag- 
ment loses a hydrogen atom in the process. Ions formed 
in the same way for the other CHR-C(0) bonds are 
labeled as a2-a6. They are obviously not structurally 
identical to the ions evolving from protonated pep- 
tides. However, once the labels are defined for charged 
derivatives, they can be used to convey information on 
the relationship between analyte structure and the 
mass-to-charge ratio values of the fragment ions ob- 
served. 
645Daitons ---i 
Scheme II 
Having used FAB data to contrast spectra and frag- 
mentation patterns for protonated and charge-deriva- 
tized peptides, and by using this format to begin 
discussing the ions formed and nomenclature details, 
now consider the MALDI-PSD spectrum of the 
TMPP+-AC-VGVAPG-OH species (Figure 2). Although 
the spectra in Figures lb and 2 are similar, there are 
key differences. The d, ions labeled in Figure lb, 
formed by side chain losses accompanying backbone 
bond cleavage, are much less intense in the MALDI- 
PSD data. The a5 peak in Figure lb is missing in 
Figure 2. The a6 peak appears 2 u higher in the 
MALDI-PSD data than in the FAB-CAD data (other 
ions are at the same mass-to-charge ratio values). Al- 
though the basic features characteristic of charge-re- 
mote processes are retained in FAB-CAD and MALDI- 
PSD, there appear to be differences as well. Also note 
that there are no intense peaks below m/z 600 in 
Figure 2; again, these C + ions fragment mostly through 
skeletal bond cleavages throughout the peptide as op- 
posed to fragmentation within the derivatizing group. 
The remainder of the discussion will focus on the 
ions generated in the MALDI-PSD experiment. Figure 
2 will be used as the first example. In Scheme II, a H 
shift accompanies skeletal bond cleavage to form a, 
ions. Thus, the mechanistic detail of the reaction lead- 
ing to a, fragment ions from the C+ precursors that 
must be determined is the source of the shifting hydro- 
gen atom. When a CHR-C(O) bond breaks, there are 
four possible positions from which the hydrogen atom 
may shift. If an amide H shifts, an ions would have the 
structure shown in Structure 5. The amide group is 
commonly considered as the source of a shifting H 
atom [24]. Shift of an a-H is unlikely, forming a 
carbene. Shift of a /3-H yields a plausible, stable ion, 
Structure 6. The structures of the ions following a H 
shift from larger side chains may contain cyclic termi- 
Figure 2. MALDI-PSD mass spectrum of [TMPP +-AC- 
VGVAPG-OH]Br-. At the top of the figure, the structure of the 
cationic derivatized peptide is shown by indicating the charged 
TMPP-AC group shown in Figure lb as [ +I-. The peaks labeled 
with asterisks (*) correspond to TMPP+-AC moiety-related ions. 
One nanomole of the peptide was derivatized, and of this, 10 
pm01 were used to obtain this spectrum. 
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[+IwNH-CH-C-N=CHR, 
Stnlcture 5 
R2, ,R3 
w  s 
[+]~wwvrrNH-CH-C-NH-CH 
Structure 6 
nations such as that shown in Structure 7 for a -y-H 
shift. From this first example, Figure 2, an a, ion is 
formed from bond cleavage in a glycine residue, which 
only has amide and a-Hs. The as ion is missing and 
only the proline residue has no amide H, so the a,, ions 
in these experiments will be assumed to have the 
structure shown as Structure 5. 
If an amide H shifts, where does it go? The obvious 
answer is onto the neutral fragment as shown in 
Scheme IIIa. This would be a 1,2 elimination. Scheme 
IIIb shows another possibility where three products are 
formed-the ion with structure 5, the N-terminal frag- 
ment with an O=C=N -termination, and H,. This is 
analogous to the mechanisms that were proposed in 
charge-remote fragmentation of fatty acid anions, for 
example, in which C-C bonds throughout an alkyl 
chain of RCCX- are cleaved 17, 81. The ions repre- 
sented by the spectrum in Figure 2 thus suggest that 
a, ions correspond to Structure 5, and Scheme IIIa 
would best describe the unimolecular fragmentation 
through which these a,, ions are formed. 
The C-terminal a,, ion has a mass-to-charge ratio 
value 2 u higher than what would be expected, labeled 
as a6 + 2 in Figure 2. Such ions are commonly ob- 
served in these experiments. A possible mechanism for 
a, + 2 ion formation is shown in Scheme IV. If a 
“regular” an ion had formed, the neutral molecule 
eliminated would have been HCOOH or {H, + CO,). 
MALDI-PSD experiments tend to yield a, + 2 ions as 
well as a,, from the C-terminal residue, whereas FAB- 
CAD experiments do not. 
Figure 3 shows the MALDI-PSD spectrum of the 
TMPP+-AC derivative of buccalin, a peptide containing 
11 residues. Of note, there are two high mass fragment 
ions: [C+-301 and [C+-181. Such small neutral losses are 
occasionally observed in the MALDI-PSD experiment. 
The a,, peak has two components-due to an and 
a,, + 2. The spectrum shown was obtained by using 
delayed extraction (DE) [19], which allowed for better 
F 
71 f: f\” P 
[+lmNH-CH-C-NH-CH-CH 
Structure 7 
a 
R2 
y1 fl CH 0 
[+]eCH-C-N $cL---- 
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[+]mCH-C-N=CHR2 
B + H-C- 
b 
99 ’ 
[+I~CH-C-N 
2kcp 
H 
‘,c N- 
I H 
t 
717 R2 
[+]*uvwwrrCH-C-N-&H + H, 
+ O=C=N- 
Scheme III 
than unit resolution and improved mass accuracy. This 
and other DE MALDI-PSD spectra were important to 
obtain in this work to establish the accurate mass-to- 
charge ratio assignments to within less than 1 u. Again, 
a, ions predominate, except there is no as ion. Unlike 
in Figure 2, in which the a5 ion is missing, Figure 3 
shows that other ions are being formed from the third 
residue (aspartic acid), labeled d, and b,, and from a 
neighboring residue, c2. This is observed when aspar- 
tic acid residues are involved. MALDI-PSD data for 
several peptides that contain aspartic acid residues 
have been examined. Whenever aspartic acid is residue 
n, there is no a, ion. Instead, peaks representing d,, 
b,, and c,-i ions are observed. 
How and why do the aspartic acid residues radi- 
cally change the fragmentation chemistry, providing 
the option for forming a set of products and not an a, 
ion? When a b-type ion is formed at an aspartic acid 
residue, backbone amide bond cleavage is accompa- 
R2 
[+I 
I R1 it I 
-NH -CH-C-NH -C 
II 
I 
1,2 elimination 
t 
R2 RI 
[+]pNH -CH-C-NH -CH + Co, 
8 A 
Scheme IV 
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Figure 3. MALDI-PSD mass spectrum of [TMPP +-AC- 
GMDSLAFSGGL-NH,@-. The charged TMPP-AC group is indi- 
cated as [ +I-. The peaks labeled with asterisks (*) correspond 
to ThWP+-AC moiety-reIated ions. The mass-to-charge ratio val- 
ues given are monoisotopic masses. One nanomole of the peptide 
was derivatized, and of this, 10 pmol were used to obtain this 
spectrum. 
nied by a H loss from the N-terminal fragment. Again, 
possible sources of the H atom and its final location 
were considered. The aspartic acid side chain has P-H 
atoms, as do many other residues, so mechanistic pos- 
sibilities were considered in which the H shift in- 
volved the acid H at the end of the side chain. Interac- 
tion with the amide N on the C-terminal side of this 
side chain results in amide bond cleavage with a H 
shift to form a b, ion as shown in Scheme Va. A 
similar mechanism has been discussed for protonated 
peptide fragmentation [251. 
Next consider the process through which aspartic 
acid yields a d-type ion. If the aspartic acid residue 
forms an a-type ion, it would appear in the spectrum 
shown in Figure 3 at m/z 848. Instead a peak appears 
at m/z 804, 44 u lower, due to CHR-C(O) cleavage 
with accompanying partial side chain loss. A mecha- 
nism that is consistent with the observed mass of the 
d, ion, via an intermediate similar to that used in 
Scheme Va, is shown in Scheme Vb. Again, the pro- 
posed charge-remote reaction involves the same H in 
the aspartic acid side chain. 
The aspartic acid side chain appears to also interact 
with the portion of the peptide to its N-terminal side 
as well (Scheme Vc>. The NH-CHR bond is cleaved 
with a H shift onto the NH- group, to give the c2 ion 
at m/z 778 in Figure 3. Related to this mechanism is 
an observation made in the MALDI-PSD study of 
TMPP +-AC-DAENLIDSFQEIV-OH (data not shown). 
The spectrum of this charged derivative was unusual 
in that fragmentation within the TMPP+-AC group was 
observed to give a peak that could be labeled as cO. 
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[+I- NH -AH--F-NH-CH=CH2 + CO, 
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/ 
rearrangement 
&.I 
[+~wuwwNH-CH-C-NH~ + co2 
Cl+1 8 
ii P 
+ CH=CH2-C-NH-CHR,+,-Ce 
Scheme V 
The N-terminal residue is aspartic acid, which forms 
b, and d, fragment ions as well as a c0 fragment, so 
the observation is consistent with the reactions sug- 
gested here and the range over which the aspartic acid 
side chain can reach to assist in backbone bond frag- 
mentation. 
J Am Sot Mass Spectrom 1997, 8, 501-509 CHARGED PEPTIDE DERIVATIVES FOR MALDI-I’SD/MS 507 
this a, ion and the a, ion. Spectral interpretation 
begins at m/z 600. The smallest amino acid is glycine 
with a residue mass of 57 u, so the a, peak will be 
observed at a mass-to-charge ratio value of no lower 
than 602. 
l 
t  
l 
JlL 
8 
757 al3+2 
I l#r) 1500 2oQo 
m/z 
Figure 4. MALDI-PSD mass spectrum of [TMPP+-Ac- 
IWFLGPLLGLLT-N&]Br-. The charged TMPP-AC group is in- 
dicated as [ +I--. The peaks labeled with asterisks (*I correspond 
to TMPP+-AC moiety-related ions. The mass-to-charge ratio val- 
ues given are monoisotopic masses. One nanomole of the peptide 
was derivatized, and of this, 10 pmol were used to obtain this 
spectrum. 
The similarities of the three mechanisms suggest 
that the aspartic acid contains a labile H atom at a 
position that facilitates the formation of three interme- 
diates, through which low energy pathways for disso- 
ciation are available. The intermediates suggested in 
Scheme V not only facilitate the formation of the ob- 
served ions, but they create local geometric situations 
that do not allow for formation of a, ions. 
A final example is presented in Figure 4, which 
shows the DE MALDI-ESD spectrum for the TMPP+-AC 
derivative of the icaria chemotactic peptide, which 
contains 13 residues and is a C-terminal amide. Again, 
a, ions dominate the spectrum. No peaks are observed 
for as or a, ions, due to the presence of proline 
residues at these locations. There is also only a very 
small a,, peak; low intensities are common when 
glycine is encountered. A terminal a + 2 ion again 
evolves from the C-terminus. 
Interpretation of the MALDI-PSD Spectra of 
TMPP +-Ac-Derivatized Peptides 
The dominance of a, fragment ions in the MALDI-PSD 
spectra of TMPP+-Ac-derivatized peptides has a prac- 
tical implication-sequence information is contained 
in a minimal number of mass spectral peaks and the 
spectra can be interpreted easily. In the simplest situa- 
tion when only a,, ions form, the mass difference 
between adjacent mass spectral peaks, Am, corre- 
sponds to amino acid residue masses. It is useful to 
consider a “virtual” ion a, as shown in Scheme I. 
Although not observed, it has m/z 545 and represents 
the constant mass portion contained in all of the frag- 
ment ions due to the charged group. The first (N- 
terminal) residue can be determined by Am between 
Consider the spectrum shown in Figure 4 as that of 
an unknown, derivatized peptide. The first pro- 
nounced peak above m/z 600 is observed at m/z 658, 
113 u above the mass of the virtual a,, ion. This mass 
corresponds to either a leucine or an isoleucine residue. 
The second pronounced peak is at m/z 757 and indi- 
cates that the second amino acid residue must be 
valine. The third pronounced peak is at m/z 1001; the 
difference between this and the peak at m/z 757 is 
244 This value is too large for any of the 20 amino acid 
residues. When proiine is involved, no intense signals 
are observed for fragment ions from this residue. The 
244 mass difference represents the sum of two amino 
acid residues, and the residue at the N-terminal side 
must be proline. The residue mass of proline is 97, 
leaving a mass of 147, which corresponds to phenylala- 
nine. By repeating such steps, the process can be con- 
tinued. Assume that the a,, peak was too small to be 
recognized as an actual peak from the analyte. From 
a,, m/z 1495, to the next peak at 1665, the Am of 170 
must be explained. One possibility is that a proline has 
been encountered, although the total does not corre- 
spond to a common residue mass plus that for proline. 
Another possibility is that a glycine has been encoun- 
tered, which frequently gives signals that are suffi- 
ciently weak that they may be overlooked. The Am of 
170 would then indicate a G-(1/L) pair. 
Figure 3 provides a good example to consider for 
interpretation aspects, to demonstrate the approach 
when aspartic acid residues are involved. Suppose the 
process outlined has been followed and the first two 
N-terminal residues have been determined as G-M. 
Thus m/z 733 represents a2. The next substantial peak 
is at 778, with a Am of 45. This is too small to 
represent a complete residue; this Am value suggests 
the presence of an aspartic acid. If this is the case, the 
next peak should be 26 mass units higher, a d ion-m 
this case at m/z 804. The third peak of this characteris- 
tic c/d/b cluster is an additional 72 u higher, at m/z 
876. The triad of peaks with Am values of 45, 26, and 
72 identifies the next residue as aspartic acid. There are 
a variety of options at this point. One can go back to 
the peak assigned as a2 at 733, realize there is no as, 
and attempt to assign the next peak after the aspartic 
acid triad as a4. The Am between 733 and 935 is 202, 
corresponding to aspartic acid (115) plus serine (87). 
Thus, the first four residues from the N-terminus are 
G-M-D-S and the process can be continued. Although 
the process is straightforward, interpretation of pep- 
tide spectra containing a, ions is different than for 
those containing bj and yi ions. In both cases, residue 
mass values can be used. However, when a, ions are 
formed, the bonds broken are not between residues 
but within residues. 
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the additional peaks present in the high power spectra 
represent N-terminal fragment ions. 
In FAB-MS, there are some experimental parameters 
that can be varied and that are related to the desorp- 
tion/ionization process. These include fast-atom ki- 
netic energy and total ion flux. Changes in these val- 
ues, over ranges commonly available, usually do not 
yield changes in the normalized mass spectra obtained 
-the largest effect is on the total ion current gener- 
ated. In MALDI that uses instruments with a single 
wavelength nitrogen laser, one commonly used vari- 
able is the laser power/fluence. Although it is not the 
purpose of this article to evaluate the power depen- 
dence of the spectra obtained, it is important to docu- 
ment the fact that the spectra are dependent on the 
laser power used. The spectra shown were obtained 
under low power conditions-only slightly above the 
threshold power for the MALDI process. When higher 
powers are used, a larger variety of fragment ions can 
be generated, and the relative intensities of the peaks 
observed change. A higher power MALDI-PSD spec- 
trum of the TMPP+-AC derivative of H-VGVAPG-OH 
is shown in Figure 5, for comparison with that shown 
in Figure 2. At higher power conditions, the peaks 
representing the a, and Cf ions are saturated. A vari- 
ety of b,, q,, and d, ions are observed, which are not 
detected at lower powers. Thus, if one is analyzing 
isotopically labeled peptides or modified residues, and 
additional structural information is desired in addition 
to what is provided through a set of a, ions, then there 
is an option for generating more fragment ions and 
changing relative intensities in this experiment. Again, 
[+I-VGVAPGGH 
aon 700 
I 
w wo loo0 
I 
1100 
m/z 
Figure 5. MALDI-PSD mass spectrum of [ TMPP +-AC- 
VGVAPG-OH]Br- by using a higher laser power than that used 
in obtaining the spectrum shown in Figure 2. The charged TMPP- 
AC group is indicated as [ +I--. One nanomole of the peptide 
was derivatized, and of this, 10 pmol were used to obtain this 
spectrum. 
Conclusions 
When a charged group is attached to the N-terminus 
of a peptide, MALDI-PSD spectra provide a powerful 
starting point for the rapid determination of structure. 
The reactions through which fragment ions are formed 
are fundamentally different from those in which proto- 
nated peptides are the precursor ions. Although the 
chemistry is referred to as being charge-remote, be- 
cause bonds many skeletal atoms away from the charge 
fragment, not all charged derivatives yield the same 
tandem mass spectra. This is due in some cases to 
weak bonds within the added group that may become 
the preferred site of fragmentation. In other cases, 
changes may be due to the size of the group carrying 
the charge, because this group may interact with other 
portions of the molecule and stimulate the fragmenta- 
tions observed. The TMPP+-AC group discussed here 
yields exceptionally simple MALDI-PSD spectra and 
yields power-dependent results that provide an addi- 
tional dimension of information. 
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